Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line... by Yi Peng MD, De Wu MD, Jing Tang MD, Xiaobing Li MD

Get full text